- Home
- BRBS vs ORIC Comparison
BRBS vs ORIC Comparison
Compare BRBS & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRBS
- ORIC
- Stock Information
- Founded
- BRBS 1893
- ORIC 2014
- Country
- BRBS United States
- ORIC United States
- Employees
- BRBS N/A
- ORIC N/A
- Industry
- BRBS Commercial Banks
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- BRBS Finance
- ORIC Health Care
- Exchange
- BRBS Nasdaq
- ORIC Nasdaq
- Market Cap
- BRBS 326.4M
- ORIC 362.9M
- IPO Year
- BRBS N/A
- ORIC 2020
- Fundamental
- Price
- BRBS $3.75
- ORIC $11.44
- Analyst Decision
- BRBS
- ORIC Strong Buy
- Analyst Count
- BRBS 0
- ORIC 9
- Target Price
- BRBS N/A
- ORIC $18.29
- AVG Volume (30 Days)
- BRBS 1.4M
- ORIC 694.8K
- Earning Date
- BRBS 07-23-2025
- ORIC 08-11-2025
- Dividend Yield
- BRBS N/A
- ORIC N/A
- EPS Growth
- BRBS N/A
- ORIC N/A
- EPS
- BRBS N/A
- ORIC N/A
- Revenue
- BRBS $96,787,000.00
- ORIC N/A
- Revenue This Year
- BRBS N/A
- ORIC N/A
- Revenue Next Year
- BRBS N/A
- ORIC N/A
- P/E Ratio
- BRBS N/A
- ORIC N/A
- Revenue Growth
- BRBS 10.08
- ORIC N/A
- 52 Week Low
- BRBS $2.45
- ORIC $3.90
- 52 Week High
- BRBS $4.05
- ORIC $14.67
- Technical
- Relative Strength Index (RSI)
- BRBS 54.97
- ORIC 63.57
- Support Level
- BRBS $3.88
- ORIC $10.88
- Resistance Level
- BRBS $3.99
- ORIC $12.00
- Average True Range (ATR)
- BRBS 0.11
- ORIC 0.56
- MACD
- BRBS 0.01
- ORIC -0.05
- Stochastic Oscillator
- BRBS 42.31
- ORIC 64.56
About BRBS Blue Ridge Bankshares Inc.
Blue Ridge Bankshares Inc is a United States-based company engaged in offering commercial and consumer banking and financial services through its wholly-owned bank subsidiary, Blue Ridge Bank, National Association, and its non-bank financial services affiliates. The bank offers services such as checking accounts, savings accounts, money market accounts, cash management accounts, commercial and industrial loans, residential mortgages, commercial mortgages, home equity loans, consumer installment loans, investment accounts, insurance and others. It has three reportable business segments: commercial banking, mortgage banking, and holding company activities.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.